Role of fluid shear stress in regulating VWF structure, function and related blood disorders

Biorheology

Volumn 52, Issue 5-6, 2015, Pages 319-335

  Gogia, Shobhit ^a   Neelamegham, Sriram ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

ADAMTS 13; Blood; Flow chamber; Hydrodynamic force; Platelet; Rheology; Thrombosis; Von Willebrand factor

Indexed keywords

THROMBIN RECEPTOR; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; ADHESION RECEPTOR;

BIOMECHANICS; BLOOD VISCOSITY; HEMATOLOGIC DISEASE; HEMODYNAMICS; HEMOSTASIS; HUMAN; IMMOBILIZED CELL; MATHEMATICAL PARAMETERS; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SHEAR STRESS; STRUCTURE ACTIVITY RELATION; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VON WILLEBRAND DISEASE; CHEMISTRY; HYDRODYNAMICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN QUATERNARY STRUCTURE; SHEAR STRENGTH; THEORETICAL MODEL; THROMBOCYTE;

ADAM PROTEINS; ADAMTS13 PROTEIN; BLOOD PLATELETS; HEMATOLOGIC DISEASES; HUMANS; HYDRODYNAMICS; MODELS, THEORETICAL; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN STRUCTURE, QUATERNARY; SHEAR STRENGTH; VON WILLEBRAND FACTOR;

EID: 85011665822     PISSN: 0006355X     EISSN: 18785034     Source Type: Journal    
DOI: 10.3233/BIR-15061     Document Type: Review

References (96)

1. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395-424.
2. Nightingale T, Cutler D. The secretion of vonWillebrand factor from endothelial cells; an increasingly complicated story. J Thromb Haemost. 2013;11(Suppl. 1):192-201. Epub 2013/07/17.
3. Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR. Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. J Thromb Haemost. 2012;10(8):1646-52. Epub 2012/05/31.
4. Plaimauer B, Zimmermann K, Volkel D, Antoine G, Kerschbaumer R, Jenab P, et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood. 2002;100(10):3626-32.
5. Soejima K, Mimura N, Hirashima M, Maeda H, Hamamoto T, Nakagaki T, et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: Possibly, the von Willebrand factor-cleaving protease? J Biochem. 2001;130(4):475-80.
6. Hamilton KK, Fretto LJ, Grierson DS, McKee PA. Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo. J Clin Invest. 1985;76(1):261-70. Epub 1985/07/01.
7. Raife TJ, Cao W, Atkinson BS, Bedell B, Montgomery RR, Lentz SR, et al. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood. 2009;114(8):1666-74. Epub 2009/06/23.
8. Lancellotti S, Dragani A, Ranalli P, Petrucci G, Basso M, Tartaglione R, et al. Qualitative and quantitative modifications of von Willebrand factor in patients with essential thrombocythemia and controlled platelet count. J Thromb Haemost. 2015;13(7):1226-37.
9. Zhou YF, Eng ET, Zhu J, Lu C, Walz T, Springer TA. Sequence and structure relationships within von Willebrand factor. Blood. 2012;120(2):449-58.
10. Huizinga EG, Martijn van der Plas R, Kroon J, Sixma JJ, Gros P. Crystal structure of the A3 domain of human von Willebrand factor: Implications for collagen binding. Structure. 1997;5(9):1147-56. Epub 1997/10/23.
11. Zhang X, Halvorsen K, Zhang CZ,Wong WP, Springer TA. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science. 2009;324(5932):1330-4.
12. Zhou YF, Eng ET, Nishida N, Lu C, Walz T, Springer TA. A pH-regulated dimeric Bouquet in the structure of von Willebrand factor. EMBO J. 2011;30(19):4098-111.
13. Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry. 1986;25(11):3171-84.
14. Canis K, McKinnon TA, Nowak A, Haslam SM, Panico M, Morris HR, et al. Mapping the N-glycome of human von Willebrand factor. Biochem J. 2012;447(2):217-28.
15. Canis K, McKinnon TA, Nowak A, Panico M, Morris HR, Laffan M, et al. The plasma von Willebrand factor Oglycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs. J Thromb Haemost. 2010;8(1):137-45.
16. Pegon JN, Kurdi M, Casari C, Odouard S, Denis CV, Christophe OD, et al. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5. Haematologica. 2012;97(12):1855-63.
17. Saint-Lu N, Oortwijn BD, Pegon JN, Odouard S, Christophe OD, de Groot PG, et al. Identification of galectin-1 and galectin-3 as novel partners for von Willebrand factor. Arterioscler Thromb Vasc Biol. 2012;32(4):894-901.
18. Padilla A, Moake JL, Bernardo A, Ball C, Wang Y, Arya M, et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004;103(6):2150-6.
19. Rydz N, Swystun LL, Notley C, Paterson AD, Riches JJ, Sponagle K, et al. The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels. Blood. 2013;121(26):5228-37.
20. McKinnon TA, Chion AC,Millington AJ, Lane DA, Laffan MA. N-linked glycosylation of VWF modulates its interaction with ADAMTS13. Blood. 2008;111(6):3042-9.
21. Nowak AA, McKinnon TA, Hughes JM, Chion AC, Laffan MA. The O-linked glycans of human von Willebrand factor modulate its interaction with ADAMTS13. J Thromb Haemost. 2014;12(1):54-61.
22. Schulteam Esch J 2nd, Robson SC, KnoefelWT, Eisenberger CF, PeiperM, Rogiers X. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction. Br J Haematol. 2005;128(1):82-90.
23. Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions. Blood. 2012;120(1):214-22.
24. Groeneveld DJ, van Bekkum T, Cheung KL, Dirven RJ, Castaman G, Reitsma PH, et al. No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance. J Thromb Haemost. 2015;13(4):592-600.
25. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84(2):289-97.
26. Kroll MH, Hellums JD,McIntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood. 1996;88(5):1525-41. Epub 1996/09/01.
27. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: Basic principles and applications. ICTHReport - Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis. Thromb Haemost. 1986;55(3):415-35. Epub 1986/06/30.
28. Lipowsky HH, Kovalcheck S, Zweifach BW. The distribution of blood rheological parameters in the microvasculature of cat mesentery. Circ Res. 1978;43(5):738-49.
29. Shankaran H, Alexandridis P, Neelamegham S. Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood. 2003;101(7):2637-45.
30. Yago T, Lou J, Wu T, Yang J, Miner JJ, Coburn L, et al. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest. 2008;118(9):3195-207. Epub 2008/08/30.
31. Dayananda KM, Singh I, Mondal N, Neelamegham S. VonWillebrand factor self-association on platelet GpIbalpha under hydrodynamic shear: Effect on shear-induced platelet activation. Blood. 2010;116(19):3990-8.
32. Neelamegham S, Taylor AD, Burns AR, Smith CW, Simon SI. Hydrodynamic shear shows distinct roles for LFA-1 and Mac-1 in neutrophil adhesion to intercellular adhesion molecule-1. Blood. 1998;92(5):1626-38. Epub 1998/08/26.
33. Neelamegham S, Taylor AD, Hellums JD, Dembo M, Smith CW, Simon SI.Modeling the reversible kinetics of neutrophil aggregation under hydrodynamic shear. Biophys J. 1997;72(4):1527-40. Epub 1997/04/01.
34. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 1987;69(2):625-8. Epub 1987/02/01.
35. Shankaran H, Neelamegham S. Effect of secondary flow on biological experiments in the cone-plate viscometer: Methods for estimating collision frequency, wall shear stress and inter-particle interactions in non-linear flow. Biorheology. 2001;38(4):275-304. Epub 2001/10/24.
36. Shankaran H, Neelamegham S. Nonlinear flow affects hydrodynamic forces and neutrophil adhesion rates in cone-plate viscometers. Biophys J. 2001;80(6):2631-48. Epub 2001/05/24.
37. Bird RD, Stewart WE, Lightfoot EN. Transport phenomena. 2nd ed. Wiley; 2006. 905 p.
38. Bruus H. In: Theoretical microfluidics. Oxford master series in condensed matter physics. Oxford University; 2007. p. 45- 51.
39. Zhang Y, Neelamegham S. Estimating the efficiency of cell capture and arrest in flow chambers: Study of neutrophil binding via E-selectin and ICAM-1. Biophys J. 2002;83(4):1934-52. Epub 2002/09/27.
40. Arp P, Mason S. The kinetics of flowing dispersions: VIII. Doublets of rigid spheres (theoretical). Journal of colloid and interface science. 1977;61(1):21-43.
41. Shankaran H, Neelamegham S. Hydrodynamic forces applied on intercellular bonds, soluble molecules, and cell-surface receptors. Biophys J. 2004;86(1 Pt 1):576-88.
42. Tha SP, Goldsmith HL. Interaction forces between red cells agglutinated by antibody. I. Theoretical Biophys J. 1986;50(6):1109-16. Epub 1986/12/01.
43. Fowler WE, Fretto LJ, Hamilton KK, Erickson HP, McKee PA. Substructure of human von Willebrand factor. J Clin Invest. 1985;76(4):1491-500. Epub 1985/10/01.
44. Singh I, Shankaran H, Beauharnois ME, Xiao Z, Alexandridis P, Neelamegham S. Solution structure of human von Willebrand factor studied using small angle neutron scattering. J Biol Chem. 2006;281(50):38266-75. Epub 2006/10/21.
45. Dong JF, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, et al. ADAMTS13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100(12):4033-9. Epub 2002/10/24.
46. Barg A, Ossig R, Goerge T, Schneider MF, Schillers H, Oberleithner H, et al. Soluble plasma-derived vonWillebrand factor assembles to a haemostatically active filamentous network. Thromb Haemost. 2007;97(4):514-26. Epub 2007/03/30.
47. Colace TV, Diamond SL. Direct observation of von Willebrand factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow. Arterioscler Thromb Vasc Biol. 2013;33(1):105-13.
48. Clift R, Grace JR, Weber ME. Bubbles, drops and particles. New York, USA: Academic Press; 1978.
49. Goldman AJ, Cox RG, Brenner H. Slow viscous motion of a sphere parallel to a plane wall - II. Couette flow. Chemical Engineering Science. 1967;22:653-60.
50. Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci USA. 2007;104(19):7899-903.
51. Singh I, Themistou E, Porcar L, Neelamegham S. Fluid shear induces conformation change in human blood protein von Willebrand factor in solution. Biophys J. 2009;96(6):2313-20.
52. Themistou E, Singh I, Shang C, Balu-Iyer SV, Alexandridis P, Neelamegham S. Application of fluorescence spectroscopy to quantify shear-induced protein conformation change. Biophys J. 2009;97(9):2567-76.
53. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood. 1996;88(8):2939-50.
54. Vergauwe RM, Uji-i H, De Ceunynck K, Vermant J, Vanhoorelbeke K, Hofkens J. Shear-stress-induced conformational changes of vonWillebrand factor in a water-glycerol mixture observed with single molecule microscopy. J Phys Chem B. 2014;118(21):5660-9.
55. Novak L, Deckmyn H, Damjanovich S, Harsfalvi J. Shear-dependent morphology of von Willebrand factor bound to immobilized collagen. Blood. 2002;99(6):2070-6. Epub 2002/03/06.
56. Raghavachari M, Tsai H, Kottke-Marchant K, Marchant RE. Surface dependent structures of von Willebrand factor observed by AFM under aqueous conditions. Colloids Surf B Biointerfaces. 2000;19(4):315-24. Epub 2000/11/07.
57. Savage B, Sixma JJ, Ruggeri ZM. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Natl Acad Sci USA. 2002;99(1):425-30.
58. Huang J, Roth R, Heuser JE, Sadler JE. Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress. Blood. 2009;113(7):1589-97. Epub 2008/10/18.
59. Ganderton T, Wong JW, Schroeder C, Hogg PJ. Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain. Blood. 2011;118(19):5312-8.
60. Choi H, Aboulfatova K, Pownall HJ, Cook R, Dong JF. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem. 2007;282(49):35604-11.
61. Li Y, Choi H, Zhou Z, Nolasco L, Pownall HJ, Voorberg J, et al. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions. J Thromb Haemost. 2008;6(7):1135-43.
62. Pimanda JE, Ganderton T, Maekawa A, Yap CL, Lawler J, Kershaw G, et al. Role of thrombospondin-1 in control of von Willebrand factor multimer size in mice. J Biol Chem. 2004;279(20):21439-48.
63. Bao J, Xiao J, Mao Y, Zheng XL. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large vonWillebrand factor string formation under flow in a free-thiol-dependent manner. Arterioscler Thromb Vasc Biol. 2014;34(2):397-407.
64. Chen J, Reheman A, Gushiken FC, Nolasco L, Fu X, Moake JL, et al. N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. J Clin Invest. 2011;121(2):593-603.
65. Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106(3):922-4.
66. Zhou W, Inada M, Lee TP, Benten D, Lyubsky S, Bouhassira EE, et al. ADAMTS13 is expressed in hepatic stellate cells. Lab Invest. 2005;85(6):780-8.
67. Turner N, Nolasco L, Tao Z, Dong JF, Moake J. Human endothelial cells synthesize and release ADAMTS13. J Thromb Haemost. 2006;4(6):1396-404.
68. Tati R, Kristoffersson AC, Stahl AL, Morgelin M, Motto D, Satchell S, et al. Phenotypic expression of ADAMTS13 in glomerular endothelial cells. PLoS One. 2011;6(6):e21587.
69. Shang D, Zheng XW, Niiya M, Zheng XL. Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts. Blood. 2006;108(7):2207-15.
70. Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, et al. Detection of von Willebrand factor-cleaving protease (ADAMTS13) in human platelets. Biochem Biophys Res Commun. 2004;313(1):212-6.
71. Liu L, Choi H, Bernardo A, Bergeron AL, Nolasco L, Ruan C, et al. Platelet-derived VWF-cleaving metalloprotease ADAMTS13. J Thromb Haemost. 2005;3(11):2536-44.
72. Zhang Q, Zhou YF, Zhang CZ, Zhang X, Lu C, Springer TA. Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci USA. 2009;106(23):9226-31.
73. Lynch CJ, Lane DA, Luken BM. Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF. Blood. 2014;123(16):2585-92.
74. Stewart DE, Sarkar A, Wampler JE. Occurrence and role of cis peptide bonds in protein structures. J Mol Biol. 1990;214(1):253-60.
75. Ramachandran GN, Mitra AK. An explanation for the rare occurrence of cis peptide units in proteins and polypeptides. J Mol Biol. 1976;107(1):85-92.
76. Brandts JF, Halvorson HR, BrennanM. Consideration of the possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry. 1975;14(22):4953-63.
77. Valiaev A, Lim DW, Oas TG, Chilkoti A, Zauscher S. Force-induced prolyl cis-trans isomerization in elastin-like polypeptides. J Am Chem Soc. 2007;129(20):6491-7.
78. Zhou M, Dong X, Baldauf C, Chen H, Zhou Y, Springer TA, et al. A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13. Blood. 2011;117(17):4623-31.
79. Jakobi AJ,Mashaghi A, Tans SJ, Huizinga EG. Calcium modulates force sensing by the vonWillebrand factor A2 domain. Nat Commun. 2011;2:385.
80. Dayananda KM, Gogia S, Neelamegham S. Escherichia coli-derived von Willebrand factor-A2 domain fluorescence/Forster resonance energy transfer proteins that quantify ADAMTS13 activity. Anal Biochem. 2011;410(2):206-13.
81. Crawley JT, de Groot R, Xiang Y, Luken BM, Lane DA. Unraveling the scissile bond: How ADAMTS13 recognizes and cleaves von Willebrand factor. Blood. 2011;118(12):3212-21.
82. Muia J, Zhu J, Gupta G, Haberichter SL, Friedman KD, Feys HB, et al. Allosteric activation of ADAMTS13 by von Willebrand factor. Proc Natl Acad Sci USA. 2014;111(52):18584-9. Epub 2014/12/17.
83. South K, Luken BM, Crawley JT, Phillips R, Thomas M, Collins RF, et al. Conformational activation of ADAMTS13. Proc Natl Acad Sci USA. 2014;111(52):18578-83. Epub 2014/12/17.
84. Bonnefoy A, Daenens K, Feys HB, De Vos R, Vandervoort P, Vermylen J, et al. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13. Blood. 2006;107(3):955-64.
85. Crawley JT, Lam JK, Rance JB, Mollica LR, O'Donnell JS, Lane DA. Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood. 2005;105(3):1085-93.
86. Wang A, Liu F, Dong N, Ma Z, Zhang J, Su J, et al. Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro. Thromb Res. 2010;126(4):e260-5.
87. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87(10):4235-44.
88. Shim K, Anderson PJ, Tuley EA,Wiswall E, Sadler JE. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood. 2008;111(2):651-7.
89. Wu T, Lin J, Cruz MA, Dong JF, Zhu C. Force-induced cleavage of single VWFA1A2A3 tridomains by ADAMTS13. Blood. 2010;115(2):370-8. Epub 2009/11/10.
90. Chauhan AK, Goerge T, Schneider SW, Wagner DD. Formation of platelet strings and microthrombi in the presence of ADAMTS13 inhibitor does not require P-selectin or beta3 integrin. J Thromb Haemost. 2007;5(3):583-9. Epub 2006/12/15.
91. Jackson SP. Arterial thrombosis - Insidious, unpredictable and deadly. Nat Med. 2011;17(11):1423-36. Epub 2011/11/09.
92. Ulrichts H, Udvardy M, Lenting PJ, Pareyn I, Vandeputte N, Vanhoorelbeke K, et al. Shielding of the A1 domain by the D′D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. J Biol Chem. 2006;281(8):4699-707.
93. Madabhushi SR, Zhang C, Kelkar A, Dayananda KM, Platelet NS. GpIba binding to von Willebrand factor under fluid shear: Contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans. J Am Heart Assoc. 2014;3(5):e001420. Epub 2014/10/25.
94. Madabhushi SR, Shang C, Dayananda KM, Rittenhouse-Olson K, Murphy M, Ryan TE, et al. Von Willebrand factor (VWF) propeptide binding to VWF D′D3 domain attenuates platelet activation and adhesion. Blood. 2012;119(20):4769-78.
95. Martin C, Morales LD, Cruz MA. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha. J Thromb Haemost. 2007;5(7):1363-70.
96. Kim J, Zhang CZ, Zhang X, Springer TA. A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature. 2010;466(7309):992-5.